Global Meloxicam Market Research Report 2022

Global Meloxicam Market Research Report 2022

Table of Contents
1 Meloxicam Market Overview
1.1 Product Overview and Scope of Meloxicam
1.2 Meloxicam Segment by Ingredient
1.2.1 Global Meloxicam Sales Growth Rate Comparison by Ingredient (2022-2028)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Meloxicam Segment by Application
1.3.1 Global Meloxicam Sales Comparison by Application: (2022-2028)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Soft Tissue Inflammation
1.3.5 Traumatic Pain
1.3.6 Post-Operative Pain
1.3.7 Other
1.4 Global Meloxicam Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Revenue 2017-2028
1.4.2 Global Meloxicam Sales 2017-2028
1.4.3 Meloxicam Market Size by Region: 2017 Versus 2021 Versus 2028
2 Meloxicam Market Competition by Manufacturers
2.1 Global Meloxicam Sales Market Share by Manufacturers (2017-2022)
2.2 Global Meloxicam Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Meloxicam Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Meloxicam Manufacturing Sites, Area Served, Product Type
2.5 Meloxicam Market Competitive Situation and Trends
2.5.1 Meloxicam Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meloxicam Players Market Share by Revenue
2.5.3 Global Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meloxicam Retrospective Market Scenario by Region
3.1 Global Meloxicam Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Meloxicam Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Meloxicam Market Facts & Figures by Country
3.3.1 North America Meloxicam Sales by Country
3.3.2 North America Meloxicam Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meloxicam Market Facts & Figures by Country
3.4.1 Europe Meloxicam Sales by Country
3.4.2 Europe Meloxicam Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meloxicam Market Facts & Figures by Region
3.5.1 Asia Pacific Meloxicam Sales by Region
3.5.2 Asia Pacific Meloxicam Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meloxicam Market Facts & Figures by Country
3.6.1 Latin America Meloxicam Sales by Country
3.6.2 Latin America Meloxicam Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meloxicam Market Facts & Figures by Country
3.7.1 Middle East and Africa Meloxicam Sales by Country
3.7.2 Middle East and Africa Meloxicam Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Meloxicam Historic Market Analysis by Type
4.1 Global Meloxicam Sales Market Share by Type (2017-2022)
4.2 Global Meloxicam Revenue Market Share by Type (2017-2022)
4.3 Global Meloxicam Price by Type (2017-2022)
5 Global Meloxicam Historic Market Analysis by Application
5.1 Global Meloxicam Sales Market Share by Application (2017-2022)
5.2 Global Meloxicam Revenue Market Share by Application (2017-2022)
5.3 Global Meloxicam Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Meloxicam Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Baudax
6.2.1 Baudax Corporation Information
6.2.2 Baudax Description and Business Overview
6.2.3 Baudax Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Baudax Meloxicam Product Portfolio
6.2.5 Baudax Recent Developments/Updates
6.3 Perrigo
6.3.1 Perrigo Corporation Information
6.3.2 Perrigo Description and Business Overview
6.3.3 Perrigo Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Perrigo Meloxicam Product Portfolio
6.3.5 Perrigo Recent Developments/Updates
6.4 Recro Pharma
6.4.1 Recro Pharma Corporation Information
6.4.2 Recro Pharma Description and Business Overview
6.4.3 Recro Pharma Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Recro Pharma Meloxicam Product Portfolio
6.4.5 Recro Pharma Recent Developments/Updates
6.5 Iroko Pharma
6.5.1 Iroko Pharma Corporation Information
6.5.2 Iroko Pharma Description and Business Overview
6.5.3 Iroko Pharma Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Iroko Pharma Meloxicam Product Portfolio
6.5.5 Iroko Pharma Recent Developments/Updates
6.6 Zyla Life Sciences
6.6.1 Zyla Life Sciences Corporation Information
6.6.2 Zyla Life Sciences Description and Business Overview
6.6.3 Zyla Life Sciences Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Zyla Life Sciences Meloxicam Product Portfolio
6.6.5 Zyla Life Sciences Recent Developments/Updates
6.7 Axsome Therapeutics
6.6.1 Axsome Therapeutics Corporation Information
6.6.2 Axsome Therapeutics Description and Business Overview
6.6.3 Axsome Therapeutics Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Axsome Therapeutics Meloxicam Product Portfolio
6.7.5 Axsome Therapeutics Recent Developments/Updates
6.8 Orbis Biosciences
6.8.1 Orbis Biosciences Corporation Information
6.8.2 Orbis Biosciences Description and Business Overview
6.8.3 Orbis Biosciences Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Orbis Biosciences Meloxicam Product Portfolio
6.8.5 Orbis Biosciences Recent Developments/Updates
6.9 Cellix Bio
6.9.1 Cellix Bio Corporation Information
6.9.2 Cellix Bio Description and Business Overview
6.9.3 Cellix Bio Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Cellix Bio Meloxicam Product Portfolio
6.9.5 Cellix Bio Recent Developments/Updates
6.10 Ligand Pharma
6.10.1 Ligand Pharma Corporation Information
6.10.2 Ligand Pharma Description and Business Overview
6.10.3 Ligand Pharma Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Ligand Pharma Meloxicam Product Portfolio
6.10.5 Ligand Pharma Recent Developments/Updates
6.11 SEDOR Pharma
6.11.1 SEDOR Pharma Corporation Information
6.11.2 SEDOR Pharma Meloxicam Description and Business Overview
6.11.3 SEDOR Pharma Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.11.4 SEDOR Pharma Meloxicam Product Portfolio
6.11.5 SEDOR Pharma Recent Developments/Updates
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Corporation Information
6.12.2 Heron Therapeutics Meloxicam Description and Business Overview
6.12.3 Heron Therapeutics Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Heron Therapeutics Meloxicam Product Portfolio
6.12.5 Heron Therapeutics Recent Developments/Updates
6.13 Pacira BioSciences
6.13.1 Pacira BioSciences Corporation Information
6.13.2 Pacira BioSciences Meloxicam Description and Business Overview
6.13.3 Pacira BioSciences Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Pacira BioSciences Meloxicam Product Portfolio
6.13.5 Pacira BioSciences Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Meloxicam Description and Business Overview
6.14.3 Sanofi Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Sanofi Meloxicam Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Eurofarma Laboratorio
6.15.1 Eurofarma Laboratorio Corporation Information
6.15.2 Eurofarma Laboratorio Meloxicam Description and Business Overview
6.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Eurofarma Laboratorio Meloxicam Product Portfolio
6.15.5 Eurofarma Laboratorio Recent Developments/Updates
6.16 TerSera Therapeutics
6.16.1 TerSera Therapeutics Corporation Information
6.16.2 TerSera Therapeutics Meloxicam Description and Business Overview
6.16.3 TerSera Therapeutics Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.16.4 TerSera Therapeutics Meloxicam Product Portfolio
6.16.5 TerSera Therapeutics Recent Developments/Updates
6.17 Apotex
6.17.1 Apotex Corporation Information
6.17.2 Apotex Meloxicam Description and Business Overview
6.17.3 Apotex Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Apotex Meloxicam Product Portfolio
6.17.5 Apotex Recent Developments/Updates
6.18 Yung Shin Pharmaceutical
6.18.1 Yung Shin Pharmaceutical Corporation Information
6.18.2 Yung Shin Pharmaceutical Meloxicam Description and Business Overview
6.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Yung Shin Pharmaceutical Meloxicam Product Portfolio
6.18.5 Yung Shin Pharmaceutical Recent Developments/Updates
6.19 Breckenridge Pharmaceutical
6.19.1 Breckenridge Pharmaceutical Corporation Information
6.19.2 Breckenridge Pharmaceutical Meloxicam Description and Business Overview
6.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Breckenridge Pharmaceutical Meloxicam Product Portfolio
6.19.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.20 Zydus Pharmaceuticals
6.20.1 Zydus Pharmaceuticals Corporation Information
6.20.2 Zydus Pharmaceuticals Meloxicam Description and Business Overview
6.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Zydus Pharmaceuticals Meloxicam Product Portfolio
6.20.5 Zydus Pharmaceuticals Recent Developments/Updates
6.21 Unichem Pharmaceuticals
6.21.1 Unichem Pharmaceuticals Corporation Information
6.21.2 Unichem Pharmaceuticals Meloxicam Description and Business Overview
6.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Unichem Pharmaceuticals Meloxicam Product Portfolio
6.21.5 Unichem Pharmaceuticals Recent Developments/Updates
6.22 Strides Pharma
6.22.1 Strides Pharma Corporation Information
6.22.2 Strides Pharma Meloxicam Description and Business Overview
6.22.3 Strides Pharma Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Strides Pharma Meloxicam Product Portfolio
6.22.5 Strides Pharma Recent Developments/Updates
6.23 Cipla
6.23.1 Cipla Corporation Information
6.23.2 Cipla Meloxicam Description and Business Overview
6.23.3 Cipla Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Cipla Meloxicam Product Portfolio
6.23.5 Cipla Recent Developments/Updates
6.24 Dr. Reddy's Laboratories
6.24.1 Dr. Reddy's Laboratories Corporation Information
6.24.2 Dr. Reddy's Laboratories Meloxicam Description and Business Overview
6.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Dr. Reddy's Laboratories Meloxicam Product Portfolio
6.24.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.25 Glenmark Pharmaceuticals
6.25.1 Glenmark Pharmaceuticals Corporation Information
6.25.2 Glenmark Pharmaceuticals Meloxicam Description and Business Overview
6.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Glenmark Pharmaceuticals Meloxicam Product Portfolio
6.25.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.26 Teva
6.26.1 Teva Corporation Information
6.26.2 Teva Meloxicam Description and Business Overview
6.26.3 Teva Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Teva Meloxicam Product Portfolio
6.26.5 Teva Recent Developments/Updates
6.27 PuraCap Pharmaceutical
6.27.1 PuraCap Pharmaceutical Corporation Information
6.27.2 PuraCap Pharmaceutical Meloxicam Description and Business Overview
6.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.27.4 PuraCap Pharmaceutical Meloxicam Product Portfolio
6.27.5 PuraCap Pharmaceutical Recent Developments/Updates
6.28 TARO
6.28.1 TARO Corporation Information
6.28.2 TARO Meloxicam Description and Business Overview
6.28.3 TARO Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.28.4 TARO Meloxicam Product Portfolio
6.28.5 TARO Recent Developments/Updates
6.29 Lupin Pharmaceuticals
6.29.1 Lupin Pharmaceuticals Corporation Information
6.29.2 Lupin Pharmaceuticals Meloxicam Description and Business Overview
6.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.29.4 Lupin Pharmaceuticals Meloxicam Product Portfolio
6.29.5 Lupin Pharmaceuticals Recent Developments/Updates
6.30 Aurobindo Pharma
6.30.1 Aurobindo Pharma Corporation Information
6.30.2 Aurobindo Pharma Meloxicam Description and Business Overview
6.30.3 Aurobindo Pharma Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.30.4 Aurobindo Pharma Meloxicam Product Portfolio
6.30.5 Aurobindo Pharma Recent Developments/Updates
6.31 Shanghai Bolinger Ingelheim Pharmaceutical
6.31.1 Shanghai Bolinger Ingelheim Pharmaceutical Corporation Information
6.31.2 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Description and Business Overview
6.31.3 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.31.4 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Portfolio
6.31.5 Shanghai Bolinger Ingelheim Pharmaceutical Recent Developments/Updates
6.32 Shanghai Zhaohui Pharmaceutical
6.32.1 Shanghai Zhaohui Pharmaceutical Corporation Information
6.32.2 Shanghai Zhaohui Pharmaceutical Meloxicam Description and Business Overview
6.32.3 Shanghai Zhaohui Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.32.4 Shanghai Zhaohui Pharmaceutical Meloxicam Product Portfolio
6.32.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
6.33 Sichuan Shenghe Pharmaceutical
6.33.1 Sichuan Shenghe Pharmaceutical Corporation Information
6.33.2 Sichuan Shenghe Pharmaceutical Meloxicam Description and Business Overview
6.33.3 Sichuan Shenghe Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.33.4 Sichuan Shenghe Pharmaceutical Meloxicam Product Portfolio
6.33.5 Sichuan Shenghe Pharmaceutical Recent Developments/Updates
6.34 Ningxia Kangya Pharmaceutical
6.34.1 Ningxia Kangya Pharmaceutical Corporation Information
6.34.2 Ningxia Kangya Pharmaceutical Meloxicam Description and Business Overview
6.34.3 Ningxia Kangya Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.34.4 Ningxia Kangya Pharmaceutical Meloxicam Product Portfolio
6.34.5 Ningxia Kangya Pharmaceutical Recent Developments/Updates
6.35 Yangtze Pharmaceutical Group
6.35.1 Yangtze Pharmaceutical Group Corporation Information
6.35.2 Yangtze Pharmaceutical Group Meloxicam Description and Business Overview
6.35.3 Yangtze Pharmaceutical Group Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.35.4 Yangtze Pharmaceutical Group Meloxicam Product Portfolio
6.35.5 Yangtze Pharmaceutical Group Recent Developments/Updates
6.36 Kunshan Longdeng Ruidi Pharmaceutical
6.36.1 Kunshan Longdeng Ruidi Pharmaceutical Corporation Information
6.36.2 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Description and Business Overview
6.36.3 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.36.4 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Product Portfolio
6.36.5 Kunshan Longdeng Ruidi Pharmaceutical Recent Developments/Updates
6.37 Jiangsu Yabang Epson Pharmaceutical
6.37.1 Jiangsu Yabang Epson Pharmaceutical Corporation Information
6.37.2 Jiangsu Yabang Epson Pharmaceutical Meloxicam Description and Business Overview
6.37.3 Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.37.4 Jiangsu Yabang Epson Pharmaceutical Meloxicam Product Portfolio
6.37.5 Jiangsu Yabang Epson Pharmaceutical Recent Developments/Updates
6.38 Jiangsu Feima Pharmaceutical Co. , Ltd
6.38.1 Jiangsu Feima Pharmaceutical Co. , Ltd Corporation Information
6.38.2 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Description and Business Overview
6.38.3 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.38.4 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Product Portfolio
6.38.5 Jiangsu Feima Pharmaceutical Co. , Ltd Recent Developments/Updates
6.39 Zhejiang Xianju Pharmaceutical
6.39.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.39.2 Zhejiang Xianju Pharmaceutical Meloxicam Description and Business Overview
6.39.3 Zhejiang Xianju Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.39.4 Zhejiang Xianju Pharmaceutical Meloxicam Product Portfolio
6.39.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.40 Hainan All Star Pharmaceutical
6.40.1 Hainan All Star Pharmaceutical Corporation Information
6.40.2 Hainan All Star Pharmaceutical Meloxicam Description and Business Overview
6.40.3 Hainan All Star Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2017-2022)
6.40.4 Hainan All Star Pharmaceutical Meloxicam Product Portfolio
6.40.5 Hainan All Star Pharmaceutical Recent Developments/Updates
6.41 Hainan Aomeihua Pharmaceutical
6.42 Hunan Mingrui Pharmaceutical
6.43 Suzhou Sinochem Pharmaceutical
6.44 Qilu Pharmaceutical
6.45 Sichuan Luye Pharmaceutical
6.46 Shandong Xinhua Pharmaceutical
6.47 Guangdong Renkang Pharmaceutical
6.48 Hainan Selike Pharmaceutical
7 Meloxicam Manufacturing Cost Analysis
7.1 Meloxicam Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meloxicam
7.4 Meloxicam Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meloxicam Distributors List
8.3 Meloxicam Customers
9 Meloxicam Market Dynamics
9.1 Meloxicam Industry Trends
9.2 Meloxicam Market Drivers
9.3 Meloxicam Market Challenges
9.4 Meloxicam Market Restraints
10 Global Market Forecast
10.1 Meloxicam Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meloxicam by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Meloxicam by Type (2023-2028)
10.2 Meloxicam Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meloxicam by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Meloxicam by Application (2023-2028)
10.3 Meloxicam Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meloxicam by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Meloxicam by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Meloxicam Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Meloxicam Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Meloxicam Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Meloxicam Market Competitive Situation by Manufacturers in 2021
Table 5. Global Meloxicam Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Meloxicam Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Meloxicam Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Meloxicam Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Meloxicam Average Price (US$/G) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Meloxicam Manufacturing Sites and Area Served
Table 11. Manufacturers Meloxicam Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meloxicam by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Meloxicam Sales by Region (2017-2022) & (KG)
Table 16. Global Meloxicam Sales Market Share by Region (2017-2022)
Table 17. Global Meloxicam Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Meloxicam Revenue Market Share by Region (2017-2022)
Table 19. North America Meloxicam Sales by Country (2017-2022) & (KG)
Table 20. North America Meloxicam Sales Market Share by Country (2017-2022)
Table 21. North America Meloxicam Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Meloxicam Revenue Market Share by Country (2017-2022)
Table 23. Europe Meloxicam Sales by Country (2017-2022) & (KG)
Table 24. Europe Meloxicam Sales Market Share by Country (2017-2022)
Table 25. Europe Meloxicam Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Meloxicam Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Meloxicam Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Meloxicam Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Meloxicam Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Meloxicam Revenue Market Share by Region (2017-2022)
Table 31. Latin America Meloxicam Sales by Country (2017-2022) & (KG)
Table 32. Latin America Meloxicam Sales Market Share by Country (2017-2022)
Table 33. Latin America Meloxicam Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Meloxicam Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Meloxicam Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Meloxicam Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Meloxicam Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Meloxicam Revenue Market Share by Country (2017-2022)
Table 39. Global Meloxicam Sales by Type (2017-2022) & (KG)
Table 40. Global Meloxicam Sales Market Share by Type (2017-2022)
Table 41. Global Meloxicam Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Meloxicam Revenue Share by Type (2017-2022)
Table 43. Global Meloxicam Price by Type (2017-2022) & (US$/G)
Table 44. Global Meloxicam Sales (KG) by Application (2017-2022)
Table 45. Global Meloxicam Sales Market Share by Application (2017-2022)
Table 46. Global Meloxicam Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Meloxicam Revenue Share by Application (2017-2022)
Table 48. Global Meloxicam Price by Application (2017-2022) & (US$/G)
Table 49. Boehringer Ingelheim Corporation Information
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 52. Boehringer Ingelheim Meloxicam Product
Table 53. Boehringer Ingelheim Recent Developments/Updates
Table 54. Baudax Corporation Information
Table 55. Baudax Description and Business Overview
Table 56. Baudax Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 57. Baudax Meloxicam Product
Table 58. Baudax Recent Developments/Updates
Table 59. Perrigo Corporation Information
Table 60. Perrigo Description and Business Overview
Table 61. Perrigo Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 62. Perrigo Meloxicam Product
Table 63. Perrigo Recent Developments/Updates
Table 64. Recro Pharma Corporation Information
Table 65. Recro Pharma Description and Business Overview
Table 66. Recro Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 67. Recro Pharma Meloxicam Product
Table 68. Recro Pharma Recent Developments/Updates
Table 69. Iroko Pharma Corporation Information
Table 70. Iroko Pharma Description and Business Overview
Table 71. Iroko Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 72. Iroko Pharma Meloxicam Product
Table 73. Iroko Pharma Recent Developments/Updates
Table 74. Zyla Life Sciences Corporation Information
Table 75. Zyla Life Sciences Description and Business Overview
Table 76. Zyla Life Sciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 77. Zyla Life Sciences Meloxicam Product
Table 78. Zyla Life Sciences Recent Developments/Updates
Table 79. Axsome Therapeutics Corporation Information
Table 80. Axsome Therapeutics Description and Business Overview
Table 81. Axsome Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 82. Axsome Therapeutics Meloxicam Product
Table 83. Axsome Therapeutics Recent Developments/Updates
Table 84. Orbis Biosciences Corporation Information
Table 85. Orbis Biosciences Description and Business Overview
Table 86. Orbis Biosciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 87. Orbis Biosciences Meloxicam Product
Table 88. Orbis Biosciences Recent Developments/Updates
Table 89. Cellix Bio Corporation Information
Table 90. Cellix Bio Description and Business Overview
Table 91. Cellix Bio Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 92. Cellix Bio Meloxicam Product
Table 93. Cellix Bio Recent Developments/Updates
Table 94. Ligand Pharma Corporation Information
Table 95. Ligand Pharma Description and Business Overview
Table 96. Ligand Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 97. Ligand Pharma Meloxicam Product
Table 98. Ligand Pharma Recent Developments/Updates
Table 99. SEDOR Pharma Corporation Information
Table 100. SEDOR Pharma Description and Business Overview
Table 101. SEDOR Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 102. SEDOR Pharma Meloxicam Product
Table 103. SEDOR Pharma Recent Developments/Updates
Table 104. Heron Therapeutics Corporation Information
Table 105. Heron Therapeutics Description and Business Overview
Table 106. Heron Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 107. Heron Therapeutics Meloxicam Product
Table 108. Heron Therapeutics Recent Developments/Updates
Table 109. Pacira BioSciences Corporation Information
Table 110. Pacira BioSciences Description and Business Overview
Table 111. Pacira BioSciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 112. Pacira BioSciences Meloxicam Product
Table 113. Pacira BioSciences Recent Developments/Updates
Table 114. Sanofi Corporation Information
Table 115. Sanofi Description and Business Overview
Table 116. Sanofi Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 117. Sanofi Meloxicam Product
Table 118. Sanofi Recent Developments/Updates
Table 119. Eurofarma Laboratorio Corporation Information
Table 120. Eurofarma Laboratorio Description and Business Overview
Table 121. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 122. Eurofarma Laboratorio Meloxicam Product
Table 123. Eurofarma Laboratorio Recent Developments/Updates
Table 124. TerSera Therapeutics Corporation Information
Table 125. TerSera Therapeutics Description and Business Overview
Table 126. TerSera Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 127. TerSera Therapeutics Meloxicam Product
Table 128. TerSera Therapeutics Recent Developments/Updates
Table 129. Apotex Corporation Information
Table 130. Apotex Description and Business Overview
Table 131. Apotex Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 132. Apotex Meloxicam Product
Table 133. Apotex Recent Developments/Updates
Table 134. Yung Shin Pharmaceutical Corporation Information
Table 135. Yung Shin Pharmaceutical Description and Business Overview
Table 136. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 137. Yung Shin Pharmaceutical Meloxicam Product
Table 138. Yung Shin Pharmaceutical Recent Developments/Updates
Table 139. Breckenridge Pharmaceutical Corporation Information
Table 140. Breckenridge Pharmaceutical Description and Business Overview
Table 141. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 142. Breckenridge Pharmaceutical Meloxicam Product
Table 143. Breckenridge Pharmaceutical Recent Developments/Updates
Table 144. Zydus Pharmaceuticals Corporation Information
Table 145. Zydus Pharmaceuticals Description and Business Overview
Table 146. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 147. Zydus Pharmaceuticals Meloxicam Product
Table 148. Zydus Pharmaceuticals Recent Developments/Updates
Table 149. Unichem Pharmaceuticals Corporation Information
Table 150. Unichem Pharmaceuticals Description and Business Overview
Table 151. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 152. Unichem Pharmaceuticals Meloxicam Product
Table 153. Unichem Pharmaceuticals Recent Developments/Updates
Table 154. Strides Pharma Corporation Information
Table 155. Strides Pharma Description and Business Overview
Table 156. Strides Pharma Meloxicam Sales (KG), Revenue (US$

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs